These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18315783)

  • 1. The effect of piracetam on ataxia: clinical observations in a group of autosomal dominant cerebellar ataxia patients.
    Ince Gunal D; Agan K; Afsar N; Borucu D; Us O
    J Clin Pharm Ther; 2008 Apr; 33(2):175-8. PubMed ID: 18315783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy.
    Vural M; Ozekmekçi S; Apaydin H; Altinel A
    Mov Disord; 2003 Apr; 18(4):457-9. PubMed ID: 12671958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group.
    Ikeda A; Shibasaki H; Tashiro K; Mizuno Y; Kimura J
    Mov Disord; 1996 Nov; 11(6):691-700. PubMed ID: 8914096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of pharmacological treatment in the compensation of vertigo].
    Pons Rocher F
    An Otorrinolaringol Ibero Am; 1999; 26(3):271-91. PubMed ID: 10394686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.
    du Montcel ST; Charles P; Ribai P; Goizet C; Le Bayon A; Labauge P; Guyant-Maréchal L; Forlani S; Jauffret C; Vandenberghe N; N'guyen K; Le Ber I; Devos D; Vincitorio CM; Manto MU; Tison F; Hannequin D; Ruberg M; Brice A; Durr A
    Brain; 2008 May; 131(Pt 5):1352-61. PubMed ID: 18378516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of myoclonus in SCA2 by piracetam.
    De Rosa A; Striano P; Barbieri F; de Falco A; Rinaldi C; Tucci T; Striano S; Filla A; De Michele G
    Mov Disord; 2006 Jan; 21(1):116-8. PubMed ID: 16149096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I treatment for cerebellar ataxia: addressing a common pathway in the pathological cascade?
    Fernandez AM; Carro EM; Lopez-Lopez C; Torres-Aleman I
    Brain Res Brain Res Rev; 2005 Dec; 50(1):134-41. PubMed ID: 15950289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium channel blocker 4-aminopyridine is effective in interictal cerebellar symptoms in episodic ataxia type 2--a video case report.
    Löhle M; Schrempf W; Wolz M; Reichmann H; Storch A
    Mov Disord; 2008 Jul; 23(9):1314-6. PubMed ID: 18442126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observations concerning piracetam treatment of patients after craniocerebral injury].
    Gościński I; Moskała M; Cichoński J; Polak J; Krupa M; Sliwonik S; Sondej T
    Przegl Lek; 1999; 56(2):119-20. PubMed ID: 10375942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Buspirone in the treatment of cerebellar ataxia].
    Svetel M; Vojvodić N; Filipović SR; Dragasević N; Sternić N; Kostić VS
    Srp Arh Celok Lek; 1999; 127(9-10):312-5. PubMed ID: 10649900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hereditary ataxias].
    Tallaksen CM
    Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1977-80. PubMed ID: 18787576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M
    Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
    Güngör L; Terzi M; Onar MK
    Brain Lang; 2011 Apr; 117(1):23-7. PubMed ID: 21227483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
    Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
    Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physostigmine in treatment of cerebellar ataxia].
    Aschoff JC; Kailer NA; Walter K
    Nervenarzt; 1996 Apr; 67(4):311-8. PubMed ID: 8684510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regression of human cerebellar ataxia under long term administration of 5-hydroxytryptophan].
    Trouillas P; Garde A; Robert JM; Adeleine P
    C R Seances Acad Sci III; 1981 Jan; 292(1):119-22. PubMed ID: 6786764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of piracetam in vertigo.
    Oosterveld WJ
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():54-60. PubMed ID: 10338110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic epidemiological study of 16q22.1-linked autosomal dominant cerebellar ataxia in western Japan.
    Hayashi M; Adachi Y; Mori M; Nakano T; Nakashima K
    Acta Neurol Scand; 2007 Aug; 116(2):123-7. PubMed ID: 17661799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of piracetam on urea-induced myoclonus in rats].
    Nanri M; Yamamoto A; Matsuura N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 May; 20(2):45-50. PubMed ID: 11062861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piracetam in the treatment of myoclonus: an overview.
    Van Vleymen B; Van Zandijcke M
    Acta Neurol Belg; 1996 Dec; 96(4):270-80. PubMed ID: 9008776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.